Press Releases

U.S. publication of a patent application covering the MDMA-N-acylethanolamines combination expands intellectual property generated through the collaboration, and provides guidance addressing clinical development considerations for psychedelic drugs, including MDMA TEL AVIV, Israel, Aug. 24, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that its  subsidiary, NeuroThera Labs Inc. (TSXV:NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, ,today announced that its ongoing collaboration with Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind") has advanced wi

MONETT, Mo., Aug. 24, 2026 /PRNewswire/ -- Jack Henry & Associates, Inc. (NASDAQ:JKHY) today announced its Board of Directors maintained its quarterly cash dividend of $.61 per share. The cash dividend on its common stock, par value $.01 per share, is payable on September 23, 2026, to stockholders of record as of September 7, 2026. Jack Henry has paid consecutive quarterly dividends since 1991, and 2025 marked the 22nd consecutive year of an increasing dividend. About Jack Henry & Associates, Inc.®Jack Henry® (NASDAQ:JKHY) is a well-rounded financial technology company that strengthens connections between financial institutions

Experienced commercial banking leader brings more than two decades of client, community leadershipNASHVILLE, Tenn., Aug. 24, 2026 /PRNewswire/ -- Truist Financial Corporation today announced Shirley Morejon has been named regional president of Tennessee, a fast-growing and increasingly competitive market. Morejon replaces Johnny Moore, who was recently named head of commercial banking integration to focus on strengthening and scaling partnerships across Truist's commercial banking, wealth management and wholesale payments businesses to better serve clients.Morejon brings more than 20 years of banking leadership across commercia

Mr. Reger brings proven public-company, capital-markets, and energy-sector leadership to advance Callan Power’s domestic manufacturing and critical electrical-infrastructure strategy SPRING BRANCH, Texas, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), a diversified company focused on logistics, emergency preparedness and critical infrastructure, confirms that, effective upon the closing of its previously announced acquisition of assets from Reger Oil, Inc, Michael Reger will serve as President of Callan Power LLC, the Company’s new wholly owned subsidiary focused on development of oil and gas resources, energy resilience, grid reliability

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, today announced that it will present new clinical and real-world data across its transthyretin-mediated amyloidosis (ATTR) and hypertension programs at the European Society of Cardiology (ESC) Congress 2026, taking place August 28-31, 2026, in Munich, Germany. These presentations add to the existing and growing body of evidence demonstrating strength in RNAi-powered transthyretin (TTR) silencing with AMVUTTRA® (vutrisiran) and underscore the potential of zilebesiran as an innovative treatment approach for hypertension, the leading preventable risk factor for cardiovascular disease (CVD) worldwide. "We're e

Bitmine owns 4.8% of the total ETH coin supply of 120.7 millionBitmine is 97% of the way to the 'Alchemy of 5%' in just 14 monthsETH gained 30% in the past week, the largest weekly gain since May 2025 and July 2021. Both precedent instances were followed by subsequent gains of +170% and +167%, respectively.Bitmine was added to the Russell 1000 Large-cap index on June 26, 2026Bitmine's Series A Preferred Stock is trading on the NYSE under the symbol BMNPBitmine has 5,067,309 staked ETH, representing $12.4 billion at $2,440 per ETH. MAVAN (Made in America VAlidator Network) is a premier Ethereum staking destination for BMNR and institutional investorsBitmine owns $89 million of Eightco (NASDAQ

Delivers Letter to the CVRx Board Highlighting Significant Value Proposition of Barostim to a Large Medical Device Company with Established Infrastructure to Capitalize on the Product's Market PositionBLOOMFIELD HILLS, Mich., Aug. 24, 2026 /PRNewswire/ -- Jorey Chernett, Founder of Pointillist Family Office and beneficial owner of more than 5.5% of the outstanding shares of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ:CVRX), today delivered a letter to the CVRx Board of Directors (the "Board"), urging it to launch an immediate and formal process to sell the Company to a strategic acquirer. In the letter, Mr. Chernett outlines why CVRx, through its Barostim pro

Now compare self-drive and chauffeur-driven Intercity options within the Zoomcar appBENGALURU, India and NEW YORK, Aug. 24, 2026 /PRNewswire/ -- Zoomcar (OTCQB:ZCAR), India's leading peer-to-peer car-sharing platform, and Uber (NYSE:UBER), India's most-loved ride-hailing app, have joined hands to make planning road trips easier and simpler. Now, travelers searching for a self-drive vehicle on the Zoomcar app will also be able to discover and book Uber Intercity rides in case they prefer to get chauffeur-driven cars. The partnership will give Zoomcar app users the choice to pick a self-drive option or take a back seat with an Uber Intercity driver at the wheel - comparing the options at one p

Legendary Sports Agent, Attorney, and Longtime Advocate for Human Longevity and Brain Health Joins BoardHOUSTON, Aug. 24, 2026 /PRNewswire/ -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the appointment of Leigh Steinberg to its Board of Directors. Widely regarded as the most influential sports agent of his generation, Mr. Steinberg brings five decades of dealmaking experience, a deep commitment to human longevity research, and a long record of initiat

Significant operational progress is being made under new leadership, reinforcing the Board’s decision to move past the founder-led era Better Home & Finance Holding Company (NASDAQ:BETR) ("Better" or the "Company") today announced that the Special Committee of the Board of Directors (the "Special Committee") provided an update on the Company’s leadership and operating progress. The Special Committee said: "The decision to appoint Daniel Lewis as Interim Chief Executive Officer, transition away from founder-led executive leadership and conduct a search for a permanent CEO was supported by every director other than Better’s founder and former CEO, Vishal Garg. It reflected the Board’s col

Board Determined Proposal Significantly Undervalues the BAS Business, Ignores Its Future Growth Prospects, and Lacks Critical Details to Make It Actionable H.B. Fuller Company ("H.B. Fuller" or "the Company") (NYSE:FUL), the world’s largest pureplay adhesives company, today announced that, following a thorough review supported by independent financial and legal advisors, its Board of Directors has unanimously rejected Ancora’s unsolicited, non-binding proposal to acquire its Building Adhesives Solutions ("BAS") business. The full text of H.B. Fuller’s Board's response letter is set forth below. Dear Fredrick and Jim, H.B. Fuller’s Board of Directors has carefully evaluated Ancora’s

Special Committee of the Board Has Rapidly Established a Track Record of Poor Governance and Decision Making; Lacks Skills Necessary to Set Strategy Recent Emission Rx LOI Raises Questions About Special Committee’s Judgment and Timing Mascarenhas’ Proposed Director Nominees Have Critical Industry, Financial and Governance Expertise to Guide Questor at this Pivotal Time Shareholders Holding more than 50% of the Shares Have Communicated Their Support for Mascarenhas’ Slate Dear Fellow Shareholders, I am writing to correct the record and explain why this upcoming meeting is about restoring disciplined governance, credible strategy, and shareholder-aligned leadership at Questor T

Published in Genetics in Medicine, study shows broad inpatient implementation of rapid genome sequencing significantly increased diagnostic rates and reduced time to diagnosis Children experiencing faltering growth saw striking 63% diagnostic yield GeneDx (NASDAQ:WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new data published in Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics (ACMG), in collaboration with the clinical genetics team at Seattle Children’s. The study demonstrates that implementing first-tier rapid genome sequencing (rGS) broadly across inpatient pediatri

ECG-PH clearance adds pulmonary hypertension to Tempus’ FDA-cleared AI products for atrial fibrillation and low ejection fraction Tempus AI, Inc. (NASDAQ:TEM) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Tempus ECG-PH (pulmonary hypertension), an AI-enabled software device that analyzes standard 12-lead electrocardiograms (ECGs) for signs associated with pulmonary hypertension. Tempus ECG-PH is the third FDA-cleared device in Tempus’ growing cardiovascular portfolio, expanding the company’s suite of next-generation AI products aimed at identifying patients at risk for complex cardiac conditions. PH is characterized by stiffening a

Inaugural event features the latest Genius technologies, followed by multi-city tour that brings the innovative platform to client partners across the U.S. Global Payments Inc. (NYSE:GPN), a leading payment technology and software company that powers commerce for businesses of all sizes worldwide, today announced Genius World, the company’s inaugural flagship event showcasing the full line of Genius™ solutions. Designed as a hands-on experience for merchants, operators and partners, Genius World will bring modern commerce to life, highlighting how a unified point-of-sale (POS) solution connects hardware, software and payments to simplify operations, enhance customer experiences and drive

Corpay, Inc., (NYSE:CPAY), the corporate payments company, today announced that the Company will participate in the following investor conferences: On Thursday, August 27, 2026, the Company will be attending the 2026 Deutsche Bank Technology Conference in Dana Point, CA. Management will participate in a fireside chat beginning at 3:20 pm PT. On Tuesday, September 15, 2026, the Company will be attending the Oppenheimer Fintech Leaders Conference in New York, NY. On Tuesday, September 15, 2026, the Company will be attending the FT Partners FinTech Conference in New York, NY. Investors and interested parties can access the presentation by visiting the Company’s investor relations w

Booz Allen Hamilton (NYSE:BAH) has completed its previously announced $720 million acquisition of the Ultra I&C Mission Solutions business (Ultra Mission Solutions), further strengthening its technology solutions for national security missions. Combining Ultra Mission Solutions’ defense technology software, encryption, and edge-compute products with Booz Allen’s AI-driven battle management, resilient communications, and edge infrastructure solutions strengthens Booz Allen’s portfolio of capabilities for today’s contested and fast-moving operational environments. These offerings will help warfighters connect, secure, and deploy technology at the edge and across domains, bringing advanced c

Potential for Additional $91.0 Million of Investments REDMOND, Ore., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Expion Energy, Inc., formerly known as Expion360 Inc. (NASDAQ:XPON) ("Expion" or the "Company"), a leader in energy storage solutions and delivery, has entered into a definitive agreement with certain accredited investors related to a private placement offering pursuant to which the Company is initially issuing $9.0 million in aggregate principal amount of 8% Convertible Debentures and Warrants to purchase up to 2,117,219 shares of the Company’s common stock at an initial exercise price of $4.25 per share (subject to adjustment, including in the case of certain dilutive issuances), whic

AUSTIN, Texas, Aug. 24, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Artificial intelligence has always been described as a software story, but its economics increasingly run through concrete, copper and steel. Global spending on AI infrastructure is projected to reach roughly $487 billion in 2026 and surpass $1 trillion by 2029, according to International Data Corporation figures, and much of that capital is chasing land, power and connectivity rather than chips alone. Among the companies positioning to serve that buildout is AZIO AI Holdings Inc. (NASDAQ:AZIO) (profile). The company is developing Atlas One, the first named development phase within Project Atlas, which brings t

MINNEAPOLIS, Aug. 24, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Devoted Health has issued a Medicare Advantage coverage policy for Barostim therapy, effective July 17, 2026. Devoted Health, a national health insurance company with the eighth largest Medicare Advantage enrollment in the U.S., provides coverage to approximately 466,000 Medicare Advantage members across 29 states. The new policy covers Barostim for patients meeting its current FDA-approved indication as well as